Skip to: Curated Story Group 1
Visually Open Nav.
Advertise
with us
US
US
EUROPE
APAC
CANADA
LATAM
subscribe
Open Search Field.
Home
Topics
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Business Services
Business Services
Business Services
Business Services
Business Services
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Pharmacy Management
Regulatory Services
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
Whitepapers
Magazine
CXO Awards
JUNE 2022LIFE SCIENCES REVIEW6Modern biotechnology focuses primarily on medicine. In this field, small startups, multinational pharmaceutical companies, and government research agencies develop new treatment options for rare and complex diseases, as well as genetic tests to better identify inherited diseases. Other fields of biotechnology include agriculture, alternative energy, and environmental science.Technology has always been at the heart of biotech. The emergence of advanced computing technology such as machine learning and artificial intelligence enables companies to expand the scope and scale of their research and improve efficiency in the manufacturing process--both of which reduce the time it takes for biotech firms to bring new products to market.In medicine, for example, the ability to analyze large data sets helps drugmakers identify treatments based on the cause of a disease. This has the potential to reduce the $2.6 billion price tag and the 90 percent failure rate for developing new drugs. In addition, the evolution of cloud computing technology has removed a barrier for many innovations in biotech. The ability to run applications through the cloud allows companies to store and analyze data without buying expensive computer hardware. This benefits early-stage startups, which try to limit operating expenses as much as possible, but it also helps larger and more established companies, as it makes it easier and cheaper to allocate resources for new projects.The search for preventing the spread of the COVID-19 virus has forced the scientific community to consider new ways of developing vaccines. Government agencies and biopharmaceutical companies have entered into unprecedented public-private partnerships to fund research and pool resources in this area, furthering our understanding of vaccines as a whole in the process.These trends in biotechnology show that today's biotech professionals need more than just a background in biology, chemistry, or pharmaceutical science to advance their careers. Business skills are critical for managing a research project or technical team, while technology expertise can add real-time analysis to cutting-edge research and development. Let us know your thoughts.EDITORIALThe Importance of Next-Generation Technology in the Biotechnology SpaceCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com JUNE - 6 - 2022, Vol 03, Issue - 06 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
<
Page 5
|
Page 7
>